Larimar Therapeutics, Inc. (LRMR)
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
$455.58M
Dr. Carole S. Ben-Maimon M.D.
31.00
Bala Cynwyd, PA
Jun 19, 2014
-6.37
$-1.12
1.53
10.93
0.00%
-7.45
0.67
2.06
0.00
10.93
-24.60%
-37.84%
Similar stocks (15)
Vaxcyte, Inc.
PCVX
Keros Therapeutics, Inc.
KROS
Syndax Pharmaceuticals, Inc.
SNDX
Day One Biopharmaceuticals, Inc.
DAWN
Alector, Inc.
ALEC
Celcuity Inc.
CELC
Sutro Biopharma, Inc.
STRO
Cabaletta Bio, Inc.
CABA
Coherus BioSciences, Inc.
CHRS
Ikena Oncology, Inc.
IKNA
Spero Therapeutics, Inc.
SPRO
Immuneering Corporation
IMRX
Kezar Life Sciences, Inc.
KZR
Surrozen, Inc.
SRZN
Bolt Biotherapeutics, Inc.
BOLT
ETF Exposure (26)
Invesco DWA SmallCap Momentum ETF
DWAS
0.381%
iShares Micro-Cap ETF
IWC
0.09999%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.03%
iShares Russell 2000 Growth ETF
IWO
0.02907%
iShares Russell 2000 ETF
IWM
0.0148%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
ProShares Ultra Russell2000
UWM
0.005546319518909093%
ProShares UltraPro Russell2000
URTY
0.002733987859484653%
ProShares Hedge Replication ETF
HDG
0.002332630779553215%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00111%
iShares Russell 3000 ETF
IWV
0.00106%
Dimensional U.S. Core Equity 2 ETF
DFAC
3.3327e-4%
Dimensional U.S. Equity ETF
DFUS
1.7109e-4%
Dimensional US Sustainability Core 1 ETF
DFSU
1.286e-5%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Similar stocks (15)
Vaxcyte, Inc.
PCVX
Keros Therapeutics, Inc.
KROS
Syndax Pharmaceuticals, Inc.
SNDX
Day One Biopharmaceuticals, Inc.
DAWN
Alector, Inc.
ALEC
Celcuity Inc.
CELC
Sutro Biopharma, Inc.
STRO
Cabaletta Bio, Inc.
CABA
Coherus BioSciences, Inc.
CHRS
Ikena Oncology, Inc.
IKNA
Spero Therapeutics, Inc.
SPRO
Immuneering Corporation
IMRX
Kezar Life Sciences, Inc.
KZR
Surrozen, Inc.
SRZN
Bolt Biotherapeutics, Inc.
BOLT
ETF Exposure (26)
Invesco DWA SmallCap Momentum ETF
DWAS
0.381%
iShares Micro-Cap ETF
IWC
0.09999%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.03%
iShares Russell 2000 Growth ETF
IWO
0.02907%
iShares Russell 2000 ETF
IWM
0.0148%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
ProShares Ultra Russell2000
UWM
0.005546319518909093%
ProShares UltraPro Russell2000
URTY
0.002733987859484653%
ProShares Hedge Replication ETF
HDG
0.002332630779553215%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00111%
iShares Russell 3000 ETF
IWV
0.00106%
Dimensional U.S. Core Equity 2 ETF
DFAC
3.3327e-4%
Dimensional U.S. Equity ETF
DFUS
1.7109e-4%
Dimensional US Sustainability Core 1 ETF
DFSU
1.286e-5%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%